We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Psychedelics – News and Features

A man's hand with pills spilled out of the container.

Framework Offers New Understanding on How Antidepressants Work in MDD

Researchers at the University of Colorado Anschutz Medical Campus have established a new framework for understanding how classic antidepressants work in treating major depressive disorder (MDD).

MDMA Therapy for PTSD Receives “No” Vote From FDA Advisory Committee

A key advisory panel to the US FDA has voted that midomafetamine (MDMA) is not effective nor risk-free for treating PTSD.
A hand holds a small mushroom.

Psilocybin Causes Feelings of “Oceanic Boundlessness”

A new study shows how psilocybin initiates hyperconnectivity in the brain, causing feelings of "oceanic boundlessness", providing insights into its potential use to treat psychiatric disorders.
A purple human brain.

Ketamine’s Molecular Action on Brain Network Function

New research addresses a gap in understanding how ketamine’s impact on individual neurons leads to pervasive and profound changes in brain network function.
Shrooms growing in the ground.

Psilocybin Shows Promise as a Treatment for Anorexia Nervosa

Some small clinical trials have shown that psilocybin, the active ingredient in magic mushrooms, may be a potential treatment for anorexia nervosa. The condition is characterised by cognitive inflexibility.
An abstract image of a person with flowers growing from their head.

Researchers Uncover How Psychedelics Interact With Serotonin Receptors

Researchers have shed light on how some psychedelic drugs – which show promise in patients with neuropsychiatric disorders such as depression and anxiety – bind to and activate serotonin receptors.

Psilocybin Looking “Rather Good” as an Anti-Depressant, Trial Data Shows

A meta-analysis of trials testing psilocybin-based treatments for depression has "encouraging" results. Here, we speak with the co-author of the study to learn more about how it was conducted, the key findings and implications for clinical implementation of psychedelic-based treatments.
Pink and yellow psychedelic sun pattern.

Deregulating Psychedelics To Propel Clinical Research

This article explores the need to deregulate certain psychedelic drugs, including MDMA and psilocybin, which could help people living with PTSD and treatment-resistant depression as pharmaceutical treatments to retrain neural pathways and improve these conditions.

A cannabis farm and a picture of Dr. Schlag

Overcoming Drug Propaganda to Lead Europe’s Largest Medical Cannabis Trial: A Q&A With Dr. Anne Katrin Schlag

Dr. Schlag, acting CEO of Drug Science, discusses how the research group's work rises above traditional drug messaging.
Two white mushrooms.

Psilocybin Shows Promise for Treatment-Resistant Depression – But Is It Safe?

Commonly referred to as “magic mushrooms,” psilocybin is a promising alternative treatment for people with medication-resistant depression and anxiety.